Phase 2 & 3 neurology trials · Pasadena

Neurology
research,
close to home

A neurology research clinic in Pasadena. Pick a condition to see which parts of the brain it affects, or start a 60-second prescreen for one of our open studies.

→See if you qualify +All 12 conditions

Now enrolling

Generalized myasthenia gravis · 2 studiesTwo treatments that work in different waysDetails → Alzheimer's diseaseEligibility reviewed at prescreenDetails →
Show me
Loading model
Drag to turn · click to focus
Study enrollment

Now enrolling

We're enrolling participants for three studies right now: two for generalized myasthenia gravis and one for Alzheimer's disease. Each has its own eligibility rules, so the first step is always a short prescreen. You can withdraw from a study at any time.

Now enrolling · 2 studies

Generalized myasthenia gravis (gMG)

We're studying two different investigational treatments for gMG. They work in completely different ways, so some people qualify for one study but not the other. One prescreen covers both, and your coordinator helps match you to the study that fits.

Study 1 · oral, once-daily · Phase III

A 9-month study of an investigational oral, once-daily treatment that blocks a specific immune-system protein linked to gMG muscle weakness. It is compared with a placebo over a 6-month treatment phase, followed by follow-up visits.

18–85age range
~9 mostudy length
~11clinic visits
1×/dayoral treatment

You may be eligible if you

  • Are between 18 and 85 years old
  • Have a confirmed gMG diagnosis with positive AChR antibodies
  • Have significant non-ocular symptoms, such as muscle weakness or fatigue
  • Have been on a stable gMG treatment for at least 6 months (for example NSISTs, IVIG/PLEX, FcRn antagonists or rituximab)

Study timeline

Treatment phase · 6 monthsFollow-up

Visit spacing is illustrative. Your coordinator gives you the exact schedule. A recent thymectomy (within 6 months), some recent treatments or an active infection may pause eligibility.

Study 2 · a different mechanism of action

A second investigational gMG treatment that works in a completely different way from Study 1. If you don't qualify for one study, you may still qualify for the other. Eligibility, the visit schedule and what the study involves are explained during your prescreen and coordinator call.

→Take the 60-second prescreen
Now enrolling

Alzheimer's disease

We are enrolling participants for an Alzheimer's disease study at our Pasadena clinic. Eligibility, the visit schedule and what the study involves are explained during your prescreen and a call with our study coordinator.

What to expect

  • A short online prescreen, then a call with a coordinator
  • A screening visit at our clinic to confirm eligibility
  • Study-related evaluations and care at no cost
  • Family members and caregivers can start the prescreen on someone's behalf
→Start the prescreen

Not eligible for a current study? Leave your details and we'll contact you when a matching study opens.

Opening January 2027Parkinson's disease · a new study opens at our clinic in January 2027. Take the prescreen now and we'll contact you when enrollment opens.

Study descriptions on this page are short summaries. The full details, including risks, are in each study's IRB-approved consent form, which your coordinator reviews with you.

How enrollment works

Five steps, no surprises

We explain each step before it happens, and nothing study-related starts until you've signed the consent form.

1

Prescreen

Answer a few questions online in about a minute. Your information stays confidential.

2

Coordinator call

A study coordinator reviews your answers and medical history with you and answers your questions.

3

Informed consent

You learn the study's purpose, risks and benefits. Take your time, and bring family if you like.

4

Screening visit

Exams and tests at our Pasadena clinic confirm you meet the study criteria.

5

Study visits

Regular visits track your health and the treatment, then follow-up after the study ends.

No cost for study careStudy-related evaluations and medical care are free.
CompensationMany studies pay for your time and travel. Details are shared before you enroll.
Easy to reach960 E. Green St., Pasadena. Close to public transit, with plenty of parking.
Who you'll meet

People first, then protocol

A small team that knows each participant by name. Every study is reviewed and monitored by an independent ethics board before and while it runs.

Portrait of Ashim Ahuja, principal investigator
Principal investigatorAshim Ahuja

Leads each study and oversees participant care at every visit.

Portrait of Dr. Purino, sub-investigator
Sub-investigatorDr. Purino

Works alongside the principal investigator on study visits and medical review.

Portrait of Wayne Pickerell, clinical trial manager
Clinical trial managerWayne Pickerell

Runs site operations, from study start-up to close-out.

Independent review

An Institutional Review Board approves and monitors each study.

Consent comes first

Nothing study-related starts until you've read and signed the consent form.

Leave at any time

Participation is voluntary. You can withdraw for any reason, without penalty.

Private by design

Your health information is protected under HIPAA and shared only as the consent form describes.

12 areas of study

Research mapped to the brain

Scroll through the conditions we study. The model marks the parts of the brain each one affects, and the keynotes explain what those parts do and how the condition changes them.

Sheet N-01 · Regions of interestLeft lateral view
ANT ←→ POST
4 cm

Keynotes

    ProjectQuantum Clinical Research
    DrawingRegions of interest
    StatusStudied
    ScaleNTS
    15+years running clinical research
    12neurological conditions studied
    31pharma and biotech sponsors
    5global CRO partners
    For patients & caregivers

    Access new treatments with expert care

    Taking part helps move neurology research forward, and you get close medical attention throughout.

    • Early access to investigational therapies under medical supervision
    • Free study-related evaluations and care
    • Compensation for time and travel in many studies
    • A coordinator who knows your name and your schedule
    See if you qualify →
    For sponsors & CROs

    A focused neurology site that enrolls

    We specialise in Phase 2 & 3 neurology studies: MS, myasthenia gravis, Alzheimer's, Parkinson's and more. Our Clinical Trial Manager brings 15+ years of site operations.

    • One point of coordination between site, sponsor and CRO
    • Regulatory compliance and timelines handled in-house
    • Referral base across Pasadena and the San Gabriel Valley
    • Data integrity and participant safety as standard
    Request site capabilities →
    Volunteer stories

    Real voices, real impact

    Patients and caregivers on what it was like to take part in a study at our clinic.

    “When I was diagnosed with Myasthenia Gravis, I felt uncertain about my future. Joining a clinical trial at Quantum Clinical Research gave me hope and a renewed sense of purpose.”

    DavidMyasthenia gravis

    “The team at Quantum Clinical Research treated me with so much respect and care. They made the process smooth and always kept me informed.”

    MichaelParkinson's disease

    “As a caregiver for my mother who has Alzheimer's Disease, I wanted to do more to support research into this devastating illness. The staff made the experience so seamless and welcoming.”

    Questions

    Before you enroll

    What happens during enrollment?

    We explain the study in detail, you sign an informed consent form, and then you complete the screening tests and assessments that confirm you're eligible.

    How do I know if I qualify?

    Each study has its own criteria, such as age, diagnosis and current treatment. Start with the prescreen and our team will review your eligibility with you.

    Are clinical trials safe?

    Participant safety is our top priority. Every trial follows strict ethical guidelines and is approved and monitored by regulatory bodies and an Institutional Review Board (IRB).

    Will I be paid for taking part?

    Many studies offer compensation for your time and effort. The details vary by study and are explained before you enroll.

    Can I leave a study after joining?

    Yes. Participation is voluntary, and you can withdraw at any time for any reason without penalty.

    What is a clinical trial?

    A research study with volunteers that evaluates the safety, effectiveness and potential benefits of a new treatment, therapy or intervention.

    Start here

    See if a study fits you

    Three quick steps. A coordinator reviews your answers and contacts you. Your information is used only to check eligibility.

    Follow
    Phone(626) 657-6005
    Emailinfo@qc-research.com
    Clinic960 E. Green St., Suite 310, Pasadena, CA 91106
    Step 1 of 3